BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18473803)

  • 1. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
    Galmarini CM; Popowycz F; Joseph B
    Curr Med Chem; 2008; 15(11):1072-82. PubMed ID: 18473803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidine nucleoside analogs in cancer treatment.
    Galmarini CM; Jordheim L; Dumontet C
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):717-28. PubMed ID: 14599094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments to improve the efficacy of cytotoxic nucleoside analogues.
    Jordheim LP; Galmarini CM; Dumontet C
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):163-70. PubMed ID: 18221034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside analogues and nucleobases in cancer treatment.
    Galmarini CM; Mackey JR; Dumontet C
    Lancet Oncol; 2002 Jul; 3(7):415-24. PubMed ID: 12142171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
    Galmarini CM; Mackey JR; Dumontet C
    Leukemia; 2001 Jun; 15(6):875-90. PubMed ID: 11417472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine nucleoside antimetabolites in development for the treatment of cancer.
    Parker WB; Secrist JA; Waud WR
    Curr Opin Investig Drugs; 2004 Jun; 5(6):592-6. PubMed ID: 15242246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anticancer polymeric conjugates of activated nucleoside analogues.
    Senanayake TH; Warren G; Vinogradov SV
    Bioconjug Chem; 2011 Oct; 22(10):1983-93. PubMed ID: 21863885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New nucleoside analogs for patients with hematological malignancies.
    Robak T
    Expert Opin Investig Drugs; 2011 Mar; 20(3):343-59. PubMed ID: 21320002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytotoxic nucleoside analogues--metabolism, activity and resistance].
    Jordheim LP
    Tidsskr Nor Laegeforen; 2005 Sep; 125(17):2348-50. PubMed ID: 16151491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nucleoside analogs in the treatment of solid tumors.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(4):297-305. PubMed ID: 15575597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.
    Zhang J; Visser F; King KM; Baldwin SA; Young JD; Cass CE
    Cancer Metastasis Rev; 2007 Mar; 26(1):85-110. PubMed ID: 17345146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New nucleoside analogs in the treatment of hematological disorders.
    Szafraniec SI; Stachnik KJ; Skierski JS
    Acta Pol Pharm; 2004; 61(3):223-32. PubMed ID: 15481249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older and new purine nucleoside analogs for patients with acute leukemias.
    Robak P; Robak T
    Cancer Treat Rev; 2013 Dec; 39(8):851-61. PubMed ID: 23566572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside analogues in the treatment of haematological malignancies.
    Johnson SA
    Expert Opin Pharmacother; 2001 Jun; 2(6):929-43. PubMed ID: 11585009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimers as nanocarriers for nucleoside analogues.
    Gorzkiewicz M; Klajnert-Maculewicz B
    Eur J Pharm Biopharm; 2017 May; 114():43-56. PubMed ID: 28089915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside-based anticancer drugs: Mechanism of action and drug resistance.
    Hruba L; Das V; Hajduch M; Dzubak P
    Biochem Pharmacol; 2023 Sep; 215():115741. PubMed ID: 37567317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future.
    Burke MP; Borland KM; Litosh VA
    Curr Top Med Chem; 2016; 16(11):1231-41. PubMed ID: 26369814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
    Robak T; Korycka A; Lech-Maranda E; Robak P
    Molecules; 2009 Mar; 14(3):1183-226. PubMed ID: 19325518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside transporters: biological insights and therapeutic applications.
    Choi JS; Berdis AJ
    Future Med Chem; 2012 Jul; 4(11):1461-78. PubMed ID: 22857534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancement in the development of heterocyclic nucleosides for the treatment of cancer - A review.
    Mirza AZ
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(11):836-857. PubMed ID: 31135268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.